- Home
- PODD vs RVTY Comparison
PODD vs RVTY Comparison
Compare PODD & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- RVTY
- Stock Information
- Founded
- PODD 2000
- RVTY 1937
- Country
- PODD United States
- RVTY United States
- Employees
- PODD N/A
- RVTY N/A
- Industry
- PODD Medical/Dental Instruments
- RVTY Biotechnology: Laboratory Analytical Instruments
- Sector
- PODD Health Care
- RVTY Industrials
- Exchange
- PODD Nasdaq
- RVTY Nasdaq
- Market Cap
- PODD 16.5B
- RVTY 13.9B
- IPO Year
- PODD 2007
- RVTY N/A
- Fundamental
- Price
- PODD $282.80
- RVTY $113.80
- Analyst Decision
- PODD Buy
- RVTY Buy
- Analyst Count
- PODD 16
- RVTY 11
- Target Price
- PODD $291.81
- RVTY $137.73
- AVG Volume (30 Days)
- PODD 598.2K
- RVTY 999.5K
- Earning Date
- PODD 02-20-2025
- RVTY 01-31-2025
- Dividend Yield
- PODD N/A
- RVTY 0.25%
- EPS Growth
- PODD 96.40
- RVTY N/A
- EPS
- PODD 5.78
- RVTY 2.20
- Revenue
- PODD $2,071,600,000.00
- RVTY $2,755,026,000.00
- Revenue This Year
- PODD $23.56
- RVTY $4.83
- Revenue Next Year
- PODD $18.07
- RVTY $6.20
- P/E Ratio
- PODD $48.93
- RVTY $49.50
- Revenue Growth
- PODD 22.07
- RVTY 0.16
- 52 Week Low
- PODD $160.19
- RVTY $97.32
- 52 Week High
- PODD $289.46
- RVTY $129.50
- Technical
- Relative Strength Index (RSI)
- PODD 54.94
- RVTY 42.07
- Support Level
- PODD $270.00
- RVTY $110.95
- Resistance Level
- PODD $288.95
- RVTY $116.86
- Average True Range (ATR)
- PODD 6.83
- RVTY 3.08
- MACD
- PODD -0.31
- RVTY -0.73
- Stochastic Oscillator
- PODD 65.78
- RVTY 24.03
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.